Merck & Co. ranks among the top dividend contenders, having increased payouts for 14 consecutive years. Dividend stocks ...

By Kushi Arora Kentucky Health News A bill that would have banned schools and workplaces from requiring a COVID-19 vaccine or ...

As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top ...

Data shows it can prevent six types of cancer. But anti-vaccine activists, including U.S. Health Secretary Robert F. Kennedy ...

“The effectiveness of the COVID vaccines can vary depending on which variants are targeted in the vaccine, which variants are circulating, and host factors,” said Shirin A. Mazumder, MD, and ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...

Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human papillomavirus (HPV) vaccine. Rates of precancerous lesions in women between the ...

This study, still in early stages, could help diagnose and treat PVS. Researchers aim to create vaccines with fewer side effects through further investigation.